Literature DB >> 8609824

Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation.

M Tang1, W Abplanalp, S Ayres, M T Subbiah.   

Abstract

The effect of the estrogen metabolites, 4-hydroxyestrone and 17alpha-dihydroequilin (metabolites of estradiol-17beta and equilin, respectively), were examined for antioxidant effects on plasma and lipoprotein lipid peroxidation . Lipid peroxidation was evaluated by products of both fatty acid (thiobarbituric acid-reactive substances [TBARS]) and cholesterol (oxysterols) oxidation from lipoproteins or whole plasma. Although all estrogens significantly reduced lipid peroxidation, 4-hydroxyestrone was far more potent than either equilin or 17alpha-dihydroequilin in inhibiting TBARS formation in lipoproteins induced by Cu2+. Similar effects were also noted on TBARS formation in THP-l macrophages in culture. However, 17alpha-dihydroequilin (along with equilin) strongly inhibited oxysterol formation, whereas 4-hydroxyestrone was ineffective. These studies suggest that different estrogens might act preferentially on distinct lipid substrates in exhibiting antioxidant effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609824     DOI: 10.1016/s0026-0495(96)90212-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis.

Authors:  W Gao; C Zeng; D Cai; B Liu; Y Li; X Wen; Y Chen
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

3.  A facile total synthesis of ent-17beta-estradiol and structurally related analogues.

Authors:  Zu Yun Cai; Douglas F Covey
Journal:  Steroids       Date:  2006-12-27       Impact factor: 2.668

Review 4.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

Review 5.  Mitochondrial damage: a target for new therapeutic horizons.

Authors:  Jean F Soustiel; Sarit Larisch
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

6.  Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.

Authors:  MaryFran Sowers; Daniel McConnell; Mary L Jannausch; John F Randolph; Robert Brook; Ellen B Gold; Sybil Crawford; Bill Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

7.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 8.  Mitochondrial mechanisms of estrogen neuroprotection.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang; James A Dykens
Journal:  Biochim Biophys Acta       Date:  2009-11-26

9.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

10.  Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.

Authors:  Qiang Zhang; Tingting Tu; D André d'Avignon; Michael L Gross
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.